| FINRA.org Skip to main content

Dr. Kirkman Comment On Regulatory Notice 22-08

I consider it vital that ordinary investors retain the right to invest in leveraged, inverse funds such as UVXY. During market declines, these are frequently nearly the only investments that go up, while everything else goes down together like a flock of birds. During the financial crisis of 2008, I was wiped out because I only invested in stocks which my investment letters assured me would be hardy enough to withstand any correction. Instead, I found out the hard way, they all dropped together.

Jonathan Freed Comment On Regulatory Notice 22-08

I am a 40 year old CFA Charterholder, investing for my own portfolio. I am shocked and disturbed to hear that investing in and/or trading certain products will be contingent upon certain criteria. I am investing my own capital, and feel it is against my rights to be told what I can and cannot invest in. Furthermore, I have completed extensive exams within the financial space, as well as worked for the largest global investment manager, BlackRock.

Michael Holmes Comment On Regulatory Notice 22-08

Regarding Regulatory Notice #22-08:
I am very much AGAINST the proposal to remove or restrict my access to tools that I use to maintain and enhance my financial security such as leveraged and inverse ETFs.
The fund families and brokerage houses themselves do a very good job of explaining the risks of these products. I have relied on these tools for years in conjunction with volatility-based trailing stops to manage my securities portfolio with great success.

Martin Shandling Comment On Regulatory Notice 22-08

Dear FINRA:
I want to express in the strongest terms my objection to and disappointment over what's being proposed. I own TBT and it has been enormously helpful to me especially in this period of sharply rising interest rates. Investors are sophisticated today and to prevent them from buying what are essentially hedging/loss mitigating vehicles prevents us from hedging our fixed income portfolios, which is unacceptable! Same applies to a broad range of "complex" products! Please drop this bad idea.